Comparative Effects of Oral Clonidine versus Oral Pregabalin Premedication on Hemodynamic Response to Laryngoscopy and Intubation: A Randomized Double-Blind Study
Keywords:
Clonidine; Pregabalin; Laryngoscopy; Intubation; Hemodynamic Response; Laparoscopic Cholecystectomy; Premedication.Abstract
Background: Laryngoscopy and endotracheal intubation often trigger significant hemodynamic responses that may be detrimental in high-risk patients. This study compared the efficacy of oral clonidine versus pregabalin in attenuating these responses. Methods: This prospective, double-blind, randomized study included 75 ASA I patients undergoing elective laparoscopic cholecystectomy. Patients were randomly allocated to receive either oral clonidine 5μg/kg (n=25), pregabalin 150mg (n=25), or placebo (n=25) 60 minutes before surgery. Hemodynamic parameters were recorded at baseline and at specified intervals during the perioperative period. Results: The clonidine group demonstrated superior control of heart rate (75.44±4.38 vs 82.28±3.04 vs 91.20±8.86 beats/min, p<0.001) and systolic blood pressure (115.96±2.54 vs 121.56±3.13 vs 130.12±8.26 mmHg, p<0.001) at 3 minutes post-intubation compared to pregabalin and placebo groups respectively. Mean arterial pressure was also better controlled in the clonidine group (85.52±2.90 vs 92.76±3.12 vs 96.72±5.30 mmHg, p<0.001). This superior hemodynamic control persisted throughout the surgical period. Conclusion: Oral clonidine 5μg/kg provides more effective attenuation of the hemodynamic response to laryngoscopy and intubation compared to pregabalin 150mg or placebo in ASA I patients undergoing laparoscopic cholecystectomy.
Downloads
Published
Issue
Section
License

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain copyright of their work and grant the journal the right of first publication.
This work is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly cited.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.





